Search research articles
Contact Us
Filters
Showing results (331-340 of 397) with videos related to
Page
of 40
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 19, 2014
Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic
Denis L F Jardim, Chad Tang, Debora De Melo Gagliato, et al.
Investigational New Drugs
|
September 10, 2020
Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC)
J Randolph Hecht, Kyriakos P Papadopoulos, Gerald S Falchook, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 29, 2022
Temporal Trends in Outcomes in Patients With Adrenocortical Carcinoma: A Multidisciplinary Referral-center Experience
Marilyne Daher, Jeena Varghese, Stephen K Gruschkus, et al.
Cell Reports. Medicine
|
February 11, 2025
Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancers
Stephane Champiat, Elena Garralda, Vladimir Galvao, et al.
Gynecologic Oncology
|
November 24, 2022
Selinexor in combination with weekly paclitaxel in patients with metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study with expansion phase in ovarian cancer
Shannon N Westin, Siqing Fu, Apostolia Tsimberidou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2016
Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells
Chad Tang, James W Welsh, Patricia de Groot, et al.
JCO Global Oncology
|
June 15, 2021
C/Can City Engagement Process: An Implementation Framework for Strengthening Cancer Care in Cities in Low- and Middle-Income Countries
Silvina Frech, Rebecca Morton Doherty, Maria Cristina Lesmes Duque, et al.
Cancer
|
April 23, 2014
Dual inhibition of the vascular endothelial growth factor pathway: a phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors
David S Hong, Ignacio Garrido-Laguna, Suhendan Ekmekcioglu, et al.
Cancer Research Communications
|
August 27, 2025
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase 1 Unit
Camila Braganca Xavier, Clark R Andersen, JoAnn Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 21, 2017
Liquid Biopsies Using Plasma Exosomal Nucleic Acids and Plasma Cell-Free DNA Compared with Clinical Outcomes of Patients with Advanced Cancers
Lino Möhrmann, Helen J Huang, David S Hong, et al.
Page
of 40
Search research articles
Search
Showing results (331-340 of 397) with videos related to
Sort By:
Page
of 40
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 19, 2014
Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic
Denis L F Jardim, Chad Tang, Debora De Melo Gagliato, et al.
Investigational New Drugs
|
September 10, 2020
Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC)
J Randolph Hecht, Kyriakos P Papadopoulos, Gerald S Falchook, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 29, 2022
Temporal Trends in Outcomes in Patients With Adrenocortical Carcinoma: A Multidisciplinary Referral-center Experience
Marilyne Daher, Jeena Varghese, Stephen K Gruschkus, et al.
Cell Reports. Medicine
|
February 11, 2025
Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancers
Stephane Champiat, Elena Garralda, Vladimir Galvao, et al.
Gynecologic Oncology
|
November 24, 2022
Selinexor in combination with weekly paclitaxel in patients with metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study with expansion phase in ovarian cancer
Shannon N Westin, Siqing Fu, Apostolia Tsimberidou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2016
Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells
Chad Tang, James W Welsh, Patricia de Groot, et al.
JCO Global Oncology
|
June 15, 2021
C/Can City Engagement Process: An Implementation Framework for Strengthening Cancer Care in Cities in Low- and Middle-Income Countries
Silvina Frech, Rebecca Morton Doherty, Maria Cristina Lesmes Duque, et al.
Cancer
|
April 23, 2014
Dual inhibition of the vascular endothelial growth factor pathway: a phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors
David S Hong, Ignacio Garrido-Laguna, Suhendan Ekmekcioglu, et al.
Cancer Research Communications
|
August 27, 2025
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase 1 Unit
Camila Braganca Xavier, Clark R Andersen, JoAnn Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 21, 2017
Liquid Biopsies Using Plasma Exosomal Nucleic Acids and Plasma Cell-Free DNA Compared with Clinical Outcomes of Patients with Advanced Cancers
Lino Möhrmann, Helen J Huang, David S Hong, et al.
Page
of 40